P53-Independent Ibrutinib Responses in an Eμ-Tcl1 Mouse Model Demonstrates Efficacy in High-Risk CLL

Blood Cancer Journal - United States
doi 10.1038/bcj.2016.41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy